Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duac Akne Gel versus Epiduo Gel for facial acne vulgaris
2008-002359-26Phase 4Completed
- Sponsor
- Stiefel Laboratories
- Start
- Jun 2008
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in acne vulgaris comparing Duac Akne Gel with Epiduo Gel (2 arms). Primary endpoint: Percent change in inflammatory lesion count from baseline to week 12. Started Jun 2008; status: completed.
02
Drugs
clindamycin phosphate + benzoyl peroxideadapalene
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on 2008-002359-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002359-26.